AOD-9604 Dosing Protocols Based on Clinical Research Dosing recommendations for AOD-9604 are based on extensive human research including six clinical trials that evaluated various administration routes, doses, and treatment durations
Brandt Stuttgart, Germany Our biggest problem with previous GHK-Cu suppliers was oxidation during storage
These three papers, alongside the foundational 2005 Jett paper on the hGRF(1-29)-albumin parent (PMID 15817669), form the core pharmacology stream
Thus, we suggest that SS should be sought in all patients without an obvious cause for sensory neuronopathy (e.g., paraneoplastic, viral, or drug-related), regardless of other ocular, articular, or mucocutaneous symptoms [56] (Figure 3)